A pediatric pharmaceutical company specializing in rare genetic disorders aimed to assess the real-world effectiveness and safety of its newly developed enzyme replacement therapy for pediatric patients with lysosoma
A leading biopharmaceutical company specializing in oncology treatments sought to assess the real-world effectiveness and safety of its novel targeted therapy for advanced melanoma.
Pro Pharma Research Organization (PPRO) is renowned for its expertise in pharmaceutical research and healthcare solutions.
Project-based pods in medical affairs and real-world evidence (RWE) for pharma are collaborative, cross-functional teams designed to tackle specific projects or challenges.
In Latin America, particularly in Mexico and Brazil, pharmacovigilance has gained relevance in recent decades due to increasing access to medicines and the need to ensure their safety and efficacy.
A Qualified Person for Pharmacovigilance (QPPV) is a regulatory requirement in the European Union (EU) for pharmaceutical companies involved in the marketing and distribution of medicinal products.
An audit of a pharmacovigilance (PV) department is a critical exercise to ensure that the department operates in compliance with regulatory requirements and follows best practices for monitoring and managing drug safety.